Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
2001 1
2004 1
2006 2
2008 1
2009 2
2010 2
2011 2
2012 3
2013 7
2014 1
2015 6
2016 13
2017 4
2018 6
2019 9
2020 10
2021 5
2022 8
2023 7
2024 6
2025 6
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.
Bol KF, Schreibelt G, Bloemendal M, van Willigen WW, Hins-de Bree S, de Goede AL, de Boer AJ, Bos KJH, Duiveman-de Boer T, Olde Nordkamp MAM, van Oorschot TGM, Popelier CJ, Pots JM, Scharenborg NM, van de Rakt MWMM, de Ruiter V, van Meeteren WS, van Rossum MM, Croockewit SJ, Koeneman BJ, Creemers JHA, Wortel IMN, Angerer C, Brüning M, Petry K, Dzionek A, van der Veldt AA, van Grünhagen DJ, Werner JEM, Bonenkamp JJ, Haanen JBAG, Boers-Sonderen MJ, Koornstra RHT, Boomsma MF, Aarntzen EHJ, Gotthardt M, Nagarajah J, de Witte TJM, Figdor CG, de Wilt JHW, Textor J, de Groot JWB, Gerritsen WR, de Vries IJM. Bol KF, et al. Nat Commun. 2024 Feb 23;15(1):1632. doi: 10.1038/s41467-024-45358-0. Nat Commun. 2024. PMID: 38395969 Free PMC article. Clinical Trial.
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.
Carrier A, Manghi P, Silva CAC, Lahmar I, Suissa D, Iebba V, Almonte AA, Ajami NJ, Birebent R, Laheurte C, Schreibelt G, Lemant L, Fahrner JE, de Sousa E, Berthier F, Villemonteix J, Chevalier MF, Piccinno G, Hocquet D, Lebhar I, Maeurer M, Caillat-Zucman S, Kobold S, Kroemer G, Derosa L, Launay O, Pieper DH, Vital M, Santos-Peral A, Zaucha M, García-Bengoa M, Thorn-Seshold J, Stirling H, Golden E, Bol KF, White MG, Sahasrabhojane PV, Hoballah YM, Losh JS, DePinho CR, Dondossola E, de Vries IJM, Adotevi O, Wargo JA, Rothenfußer S, Segata N, Formenti S, Zitvogel L. Carrier A, et al. Among authors: bol kf. Res Sq [Preprint]. 2025 Oct 28:rs.3.rs-4294379. doi: 10.21203/rs.3.rs-4294379/v1. Res Sq. 2025. PMID: 41282134 Free PMC article. Preprint.
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.
Alves Costa Silva C, Piccinno G, Suissa D, Bourgin M, Schreibelt G, Durand S, Birebent R, Fidelle M, Sow C, Aprahamian F, Manghi P, Punčochář M, Asnicar F, Pinto F, Armanini F, Terrisse S, Routy B, Drubay D, Eggermont AMM, Kroemer G, Segata N, Zitvogel L, Derosa L, Bol KF, de Vries IJM. Alves Costa Silva C, et al. Among authors: bol kf. Nat Commun. 2024 Feb 23;15(1):1633. doi: 10.1038/s41467-024-45357-1. Nat Commun. 2024. PMID: 38395948 Free PMC article.
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
van Ravensteijn SG, de Haan JJ, Gelderblom H, Nederkoorn MJL, Hillebrandt-Roeffen MHS, Gorris MAJ, de Bitter TJJ, Boleij A, Gusinac A, Ederveen THA, Flucke UE, Bonenkamp JJ, Speetjens FM, Kaal SEJ, Smits M, Bol KF, van Herpen CML, Versleijen-Jonkers YMH, Desar IME. van Ravensteijn SG, et al. Among authors: bol kf. Clin Cancer Res. 2025 Sep 2;31(17):3678-3691. doi: 10.1158/1078-0432.CCR-25-0311. Clin Cancer Res. 2025. PMID: 40632032 Free PMC article. Clinical Trial.
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer.
Laureano RS, Sprooten J, Vanmeerbeerk I, Borras DM, Govaerts J, Naulaerts S, Berneman ZN, Beuselinck B, Bol KF, Borst J, Coosemans A, Datsi A, Fučíková J, Kinget L, Neyns B, Schreibelt G, Smits E, Sorg RV, Spisek R, Thielemans K, Tuyaerts S, De Vleeschouwer S, de Vries IJM, Xiao Y, Garg AD. Laureano RS, et al. Among authors: bol kf. Oncoimmunology. 2022 Jul 4;11(1):2096363. doi: 10.1080/2162402X.2022.2096363. eCollection 2022. Oncoimmunology. 2022. PMID: 35800158 Free PMC article.
98 results